MCL

Practice-changing abstracts in MCL from ASH 2019

L: English
Watch German version

During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the Lymphoma Hub were pleased to speak to Martin Dreyling, University of Munich, Munich, DE. Martin Dreyling provides an overview of the practice-changing abstracts in mantle cell lymphoma from ASH 2019

Martin Dreyling talks about treatment strategies for mantle cell lymphoma (MCL). He explains MCL has been subcategorized to conventional indolent type and aggressive MCL, with each receiving a different treatment approach. He also discusses studies that focus on the treatment of MCL in the relapsed setting

Was this article informative? Thank you for your feedback!
92% of people found this article informative